AEZS Market Cap History
Below is a table of the AEZS market cap history going back to 12/31/2016:

Date AEZS Market Cap
12/31/201646.50M
12/31/201738.80M
12/31/201848.34M
12/31/201918.20M

Also see: AEZS Shares Outstanding History
and AEZS YTD Return
AEZS Historical Market Cap:
-26.86% CAGR
AEZS Historical Market Cap: +-26.86% CAGR

Mouse over chart for data details
12/31/201612/31/201712/31/201812/31/2019
AEterna Zentaris is a biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. Co.'s lead product, Macrilen™ (macimorelin) is an oral test indicated for the diagnosis of patients with adult growth hormone deficiency. Macrilen™ is marketed in the United States through a license and assignment agreement with Novo Nordisk A/S. Co. is also pursuing the development of macimorelin for the diagnosis of child-onset growth hormone deficiency. Co.'s principal focus is on the commercialization of Macrilen™ and it does not have any other approved products. We show 4 historical shares outstanding datapoints in our AEZS shares outstanding history coverage, used to compute AEZS market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing AEZS market cap history over the course of time is important for investors interested in comparing AEZS's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of AEZS versus a peer is one thing; comparing AEZS market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like AEZS can fluctuate over the course of history. With this page we aim to empower investors researching AEZS by allowing them to research the AEZS market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for AEZS:
AEZS SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
AEterna Zentaris (AEZS) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

AGEN Market Cap History
AGIO Market Cap History
AGLE Market Cap History
AGN Market Cap History
AGRX Market Cap History
AGTC Market Cap History
AHPI Market Cap History
AIMT Market Cap History
AIQ Market Cap History
AKAO Market Cap History
More Healthcare companies »

 

AEZS Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.